• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的生理和心理方面:重新审视多发性硬化症影响量表(MSIS-29)。

Physical and psychological aspects of multiple sclerosis: Revisiting the Multiple Sclerosis Impact Scale (MSIS-29).

机构信息

Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.

The Walton Centre NHS Foundation Trust, Liverpool, UK.

出版信息

Mult Scler. 2024 Nov;30(13):1630-1641. doi: 10.1177/13524585241288393. Epub 2024 Oct 30.

DOI:10.1177/13524585241288393
PMID:39474866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11568641/
Abstract

BACKGROUND

The MSIS-29 measures the physical and psychological impact of MS.

OBJECTIVE

The associations between MSIS-29 domains and demographic/clinical aspects were examined and trajectories analysed over time.

METHODS

Data were collected in the Trajectories of Outcome in Neurological Conditions study for a diverse population of people with MS, with follow-up for up to 5 years. Following Rasch analysis, minimal important change (MIC) was computed for ensuing total, physical and psychological domains.

RESULTS

Fit to the Rasch model using data from 5921 participants validated physical, psychological and total domains, and the conversion table transforms raw scores to interval-level metric equivalents. These domains showed significant differences across demographic (age, gender, employment, education, and marital status) and clinical (subtype, treatment, and duration) factors with large effect sizes. The MIC scores were physical: 9.1, total: 14.1, which were both above measurement error, and psychological: 5.5 which was not, so 1.6% of participants reported psychological change which was clinically important but not statistically significant. Trajectory analysis showed three groups, one stable and two with significant slopes, improving and deteriorating.

CONCLUSION

The MSIS-29 has shown adequate fit to the Rasch model after accommodating problems with local item dependency, through a bi-factor solution. The domains showed good discrimination across key factors.

摘要

背景

MSIS-29 衡量多发性硬化症的生理和心理影响。

目的

研究了 MSIS-29 各领域与人口统计学/临床方面的相关性,并分析了随时间的变化轨迹。

方法

在神经疾病结局轨迹研究中,对来自不同人群的多发性硬化症患者进行了数据收集,随访时间长达 5 年。在进行 Rasch 分析后,计算了随后的总评分、生理评分和心理评分的最小重要变化值(MIC)。

结果

来自 5921 名参与者的数据符合 Rasch 模型,验证了生理、心理和总分领域,转换表将原始分数转换为区间水平的度量等效值。这些领域在人口统计学(年龄、性别、就业、教育和婚姻状况)和临床(亚型、治疗和病程)因素方面存在显著差异,且具有较大的效应量。MIC 评分分别为生理:9.1,总评分:14.1,均高于测量误差,而心理评分:5.5,低于测量误差,因此有 1.6%的参与者报告了具有临床意义但无统计学意义的心理变化。轨迹分析显示,有三个组,一个稳定组和两个斜率显著的组,分别是改善组和恶化组。

结论

在通过双因子解决方案解决局部项目依存性问题后,MSIS-29 已符合 Rasch 模型的要求。各领域在关键因素方面表现出良好的区分度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd4/11568641/4cc829f088ac/10.1177_13524585241288393-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd4/11568641/166ccb1145bb/10.1177_13524585241288393-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd4/11568641/4cc829f088ac/10.1177_13524585241288393-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd4/11568641/166ccb1145bb/10.1177_13524585241288393-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd4/11568641/4cc829f088ac/10.1177_13524585241288393-fig2.jpg

相似文献

1
Physical and psychological aspects of multiple sclerosis: Revisiting the Multiple Sclerosis Impact Scale (MSIS-29).多发性硬化症的生理和心理方面:重新审视多发性硬化症影响量表(MSIS-29)。
Mult Scler. 2024 Nov;30(13):1630-1641. doi: 10.1177/13524585241288393. Epub 2024 Oct 30.
2
Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discrimination.多发性硬化症视功能问卷 (MSVQ-7):信度、效度、精密度和判别能力。
Mult Scler Relat Disord. 2023 Dec;80:105115. doi: 10.1016/j.msard.2023.105115. Epub 2023 Oct 30.
3
Rasch analysis of the Multiple Sclerosis Impact Scale MSIS-29.多发性硬化症影响量表MSIS - 29的拉施分析。
Health Qual Life Outcomes. 2009 Jun 22;7:58. doi: 10.1186/1477-7525-7-58.
4
Validation of the Arabic Version of the Multiple Sclerosis Impact Scale (MSIS-29): a Rasch Analysis Study.多发性硬化症影响量表阿拉伯语版(MSIS - 29)的验证:一项拉施分析研究。
Arch Clin Neuropsychol. 2025 Apr 27;40(3):520-528. doi: 10.1093/arclin/acae121.
5
Cross-cultural adaptation and validation of the Arabic version of the Multiple Sclerosis Impact Scale-29.《多发性硬化症影响量表29项阿拉伯语版本的跨文化适应与验证》
Disabil Rehabil. 2025 Jan;47(2):485-492. doi: 10.1080/09638288.2024.2350618. Epub 2024 May 13.
6
Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.改善多发性硬化症治疗干预措施的评估:基于患者的结局指标的开发。
Health Technol Assess. 2004 Mar;8(9):iii, 1-48. doi: 10.3310/hta8090.
7
Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale-29.多发性硬化症影响量表-29 芬兰语版的有效性和可靠性。
Brain Behav. 2017 May 17;7(7):e00725. doi: 10.1002/brb3.725. eCollection 2017 Jul.
8
Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies.多发性硬化症影响量表-29(MSIS-29)是否能够涵盖完全可独立行走的多发性硬化症患者的体验?来自ASCLEPIOS研究的经验教训。
Mult Scler J Exp Transl Clin. 2023 Sep 28;9(3):20552173231201422. doi: 10.1177/20552173231201422. eCollection 2023 Jul-Sep.
9
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.多发性硬化症影响量表(MSIS - 29):一种基于患者的新型结局指标。
Brain. 2001 May;124(Pt 5):962-73. doi: 10.1093/brain/124.5.962.
10
Italian adaptation and psychometric validation of the Fatigue Impact Scale (FIS) and its modified versions in adults with multiple sclerosis: a Rasch analysis study.意大利文版疲劳影响量表(FIS)及其改良版本在多发性硬化症成人中的适应和心理测量学验证:一项 Rasch 分析研究。
Disabil Rehabil. 2024 Nov;46(22):5366-5379. doi: 10.1080/09638288.2024.2302878. Epub 2024 Jan 18.

引用本文的文献

1
Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse activity.复发缓解型多发性硬化症患者中,与复发活动无关的病情进展会导致生活质量下降。
Mult Scler. 2025 Apr;31(5):548-557. doi: 10.1177/13524585251318516. Epub 2025 Feb 18.
2
Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study.在临床实践中接受阿仑单抗治疗的多发性硬化症患者生活质量的改善:LEMVIDA研究。
J Patient Rep Outcomes. 2024 Dec 18;8(1):148. doi: 10.1186/s41687-024-00822-9.

本文引用的文献

1
Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discrimination.多发性硬化症视功能问卷 (MSVQ-7):信度、效度、精密度和判别能力。
Mult Scler Relat Disord. 2023 Dec;80:105115. doi: 10.1016/j.msard.2023.105115. Epub 2023 Oct 30.
2
Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies.多发性硬化症影响量表-29(MSIS-29)是否能够涵盖完全可独立行走的多发性硬化症患者的体验?来自ASCLEPIOS研究的经验教训。
Mult Scler J Exp Transl Clin. 2023 Sep 28;9(3):20552173231201422. doi: 10.1177/20552173231201422. eCollection 2023 Jul-Sep.
3
Application of the Rasch measurement model in rehabilitation research and practice: early developments, current practice, and future challenges.
拉施测量模型在康复研究与实践中的应用:早期发展、当前实践及未来挑战。
Front Rehabil Sci. 2023 Jul 17;4:1208670. doi: 10.3389/fresc.2023.1208670. eCollection 2023.
4
Effect of Multiple Sclerosis on Daily Activities, Emotional Well-being, and Relationships: The Global vsMS Survey.多发性硬化症对日常活动、情绪健康及人际关系的影响:全球多发性硬化症调查
Int J MS Care. 2020 Jul-Aug;22(4):158-164. doi: 10.7224/1537-2073.2018-087. Epub 2019 Aug 28.
5
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.多发性硬化症的初始高效疾病修正治疗:一项全国性队列研究。
Neurology. 2020 Aug 25;95(8):e1041-e1051. doi: 10.1212/WNL.0000000000010135. Epub 2020 Jul 7.
6
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.多发性硬化症的诊断:2017 年麦当劳标准修订版。
Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.
7
Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT).衡量多发性硬化症的影响:运用拉施测量理论(RMT)提升多发性硬化症影响量表(MSIS - 29)的测量性能。
Mult Scler J Exp Transl Clin. 2017 Aug 15;3(3):2055217317725917. doi: 10.1177/2055217317725917. eCollection 2017 Jul-Sep.
8
Recent advances in analysis of differential item functioning in health research using the Rasch model.使用拉施模型分析健康研究中项目功能差异的最新进展。
Health Qual Life Outcomes. 2017 Sep 19;15(1):181. doi: 10.1186/s12955-017-0755-0.
9
How Do Pain, Fatigue, Depressive, and Cognitive Symptoms Relate to Well-Being and Social and Physical Functioning in the Daily Lives of Individuals With Multiple Sclerosis?疼痛、疲劳、抑郁和认知症状如何与多发性硬化症患者日常生活中的幸福感以及社会和身体功能相关?
Arch Phys Med Rehabil. 2017 Nov;98(11):2160-2166. doi: 10.1016/j.apmr.2017.07.004. Epub 2017 Jul 18.
10
Analysis of the psychometric properties of the Multiple Sclerosis Impact Scale-29 (MSIS-29) in relapsing-remitting multiple sclerosis using classical and modern test theory.运用经典和现代测试理论分析复发缓解型多发性硬化症中多发性硬化症影响量表29(MSIS - 29)的心理测量特性。
Mult Scler J Exp Transl Clin. 2016 Oct 9;2:2055217316673235. doi: 10.1177/2055217316673235. eCollection 2016 Jan-Dec.